These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 21111550)

  • 41. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am J Nurs; 2002 Mar; 102(3):67, 69-70. PubMed ID: 11976531
    [No Abstract]   [Full Text] [Related]  

  • 42. [Use of aspirin for primary prevention of cardiovascular events in diabetic patients--is it justified?].
    Benhamou Y; Lévesque H
    Rev Med Interne; 2009 Dec; 30(12):1001-3. PubMed ID: 19833416
    [No Abstract]   [Full Text] [Related]  

  • 43. [Should one prescribe aspirin for all diabetics?].
    Passa P
    Diabetes Metab; 1997 Dec; 23(6):554-6. PubMed ID: 9496565
    [No Abstract]   [Full Text] [Related]  

  • 44. Aspirin: real benefits, but real risks, too.
    Harv Heart Lett; 1999 May; 9(9):1-3. PubMed ID: 10200029
    [No Abstract]   [Full Text] [Related]  

  • 45. Aspirin for the masses.
    Aslam F; Waheed A
    J Am Coll Cardiol; 2009 Jun; 54(1):91; author reply 91-2. PubMed ID: 19555850
    [No Abstract]   [Full Text] [Related]  

  • 46. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
    Wienbergen H; Senges J; Gitt AK
    Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
    [No Abstract]   [Full Text] [Related]  

  • 47. Low-dose aspirin in the primary prevention of cardiovascular disease: how to balance the benefits and the risks.
    De Caterina R
    Ital Heart J; 2003 Apr; 4(4):228-31. PubMed ID: 12784774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Who should take aspirin for primary prophylaxis of coronary heart disease?
    Lowe GD
    Heart; 2001 Mar; 85(3):245-6. PubMed ID: 11179252
    [No Abstract]   [Full Text] [Related]  

  • 49. Who should take aspirin as CVD primary preventive?
    Manson JE
    Geriatrics; 2009 Mar; 64(3):14-5. PubMed ID: 19358366
    [No Abstract]   [Full Text] [Related]  

  • 50. Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?
    Krane V; Wanner C
    Am J Kidney Dis; 2005 Mar; 45(3):607-9. PubMed ID: 15754285
    [No Abstract]   [Full Text] [Related]  

  • 51. Weighing the benefits and risks of aspirin for primary prevention of vascular disease.
    Garg MK
    J Assoc Physicians India; 2010 May; 58():331. PubMed ID: 21117359
    [No Abstract]   [Full Text] [Related]  

  • 52. Aspirin for primary prevention of cardiovascular disease?
    Drug Ther Bull; 2009 Nov; 47(11):122-5. PubMed ID: 19887685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aspirin for all over 50 revisited.
    Elwood P; Morgan G
    Heart; 2008 Nov; 94(11):1364-5. PubMed ID: 18765435
    [No Abstract]   [Full Text] [Related]  

  • 54. A health impact assessment of increased aspirin use in Wales.
    Williams WR
    Public Health; 2006 May; 120(5):480; author reply 481. PubMed ID: 16549078
    [No Abstract]   [Full Text] [Related]  

  • 55. The benefit of aspirin therapy in type 2 diabetes: what is the evidence?
    Sirois C; Poirier P; Moisan J; Grégoire JP
    Int J Cardiol; 2008 Sep; 129(2):172-9. PubMed ID: 18495263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease.
    Spinler SA
    Pharmacotherapy; 2009 Jul; 29(7):812-21. PubMed ID: 19558255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary prevention for cardiovascular diseases: can statins replace aspirin?
    Abdul Hadi M; Ming LC; Awaisu A
    Med Princ Pract; 2011; 20(6):584. PubMed ID: 21986022
    [No Abstract]   [Full Text] [Related]  

  • 58. Aspirin in primary prevention of cardiovascular disease in the elderly.
    Galli M; Andreotti F; D'Amario D; Vergallo R; Montone RA; Porto I; Crea F
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):326-327. PubMed ID: 31504373
    [No Abstract]   [Full Text] [Related]  

  • 59. Aspirin and gastrointestinal toxicity.
    Törüner M
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():27-30. PubMed ID: 18160364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.